SCHEMBL25077809

SCHEMBL25077809

COC(=O)c1cc(Br)c(=O)n(-c2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HPGD P15428 2/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 1/20 0.46
FAAH O00519 1/20 0.45
MGLL Q99685 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 1/20 0.45
ATM Q13315 1/20 0.45
PTGS2 P35354 1/20 0.45
RPA1 P27694 1/20 0.44
ALDH1A1 P00352 2/20 0.44
POLB P06746 2/20 0.44
GAA P10253 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25078330 0.86 HPGD (0.51) SMN1; SMN2CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL25078609 0.83 HPGD (0.52) SMN1; SMN2CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL10568581 0.81 KDM4E (0.51) SMN1; SMN2CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL13239857 0.80 RPA1 (0.70) SMN1; SMN2FAAHMGLLMEN1KMT2A
SCHEMBL28644955 0.80 HPGD (0.50) SMN1; SMN2CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL69400 0.80 SMN1; SMN2 (0.60) SMN1; SMN2CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL11649636 0.78 HPGD (0.59) SMN1; SMN2CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL25078566 0.77 LMNA (0.44) SMN1; SMN2CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL25078205 0.77 SMN1; SMN2 (0.57) SMN1; SMN2CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL19186324 0.76 SMN1; SMN2 (0.41) SMN1; SMN2CYP1A2CYP2C9CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4667458-A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER, COMPRISING SOS1 INHIBITOR AND ANTICANCER DRUG Kanaph Therapeutics Inc. (KR) 2025-12-24 EP disclosed
CN-118119600-A SOS1 inhibitors and uses thereof 治纳辅医药科技有限公司 2024-05-31 CN disclosed
WO-2023022497-A1 SOS1 INHIBITOR AND USE THEREOF 주식회사 카나프테라퓨틱스 2023-02-23 WO disclosed